ASSOCIATION OF SMOKING AND BLADDER CANCER: AN UPDATED SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/58pyv510Keywords:
Bladder cancer, cigarette, kidney neoplasm, smoking, tobacco consumptionAbstract
Introduction: Bladder cancer is the 10th most common global cancer, with increasing incidence, primarily linked to smoking, occupational exposures, and genetic factors. This systematic review explores the association between tobacco use and bladder cancer, emphasizing the importance of understanding its multifactorial etiology for effective prevention.
Method: The researchers in this study followed the 2020 Preferred Reporting Items for Systematic Review and MetaAnalysis (PRISMA) guidelines to ensure that their work met the required standards. This was done to ensure the precision and reliability of the conclusions derived from the research.
Result: Our search produced 18 results. After looking at the titles and summaries, we found several papers that fit our criteria. At first, we excluded few articles because they were written in review and case report style. But after reading the full papers carefully, we included five papers in our final analysis. These papers included two-sample univariable and multivariable Mendelian Randomization (MR) analysis, case control study, prospective cohort study of patients with NMIBC diagnosed from 2015 to 2019, experimental study, and rtrospective study.
Conclusion: The systematic review involved Mendelian Randomization analysis, underscores smoking as a significant risk factor for bladder cancer, with no evidence linking alcohol consumption to the disease. In a prospective cohort study on Non-Muscle Invasive Bladder Cancer, the study establishes a dose-dependent relationship, emphasizing the urgency for effective smoking cessation interventions in patients, especially those with prolonged smoking history. Additionally, the investigation into molecular pathways reveals the upregulation of the platelet-activating factor (PAF) pathway by cigarette smoke exposure, suggesting PAF-PAF receptor (PAF-R) interaction as a promising therapeutic target for managing bladder cancer growth.
References
Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. [PubMed] [CrossRef] [Google Scholar]
Ferlay J., Ervik M., Lam F., Colombet M., Mery L., Piñeros M., Znaor A., Soerjomataram I., Bray F. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; Lyon, France: 2018. [(accessed on 10 January 2020)]. Available online: https://gco.iarc.fr/ [Google Scholar]
Andersson K.-E., Arner A. Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology. Physiol. Rev. 2004;84:935–986. doi: 10.1152/physrev.00038.2003. [PubMed] [CrossRef] [Google Scholar]
Mushtaq J., Thurairaja R., Nair R. Bladder Cancer. Surgery. 2019;37:529–537. doi: 10.1016/j.mpsur.2019.07.003. [CrossRef] [Google Scholar]
Mostafa M.H., Sheweita S., O’Connor P.J. Relationship between Schistosomiasis and Bladder Cancer. Clin. Microbiol. Rev. 1999;12:97–111. doi: 10.1128/CMR.12.1.97. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Wong M.C., Fung F.D.H., Leung C., Cheung W.W.L., Goggins W.B., Ng A.C.F. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci. Rep. 2018;8:1129. doi: 10.1038/s41598-018-19199-z. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Jamal A., Phillips E., Gentzke A.S., Homa D.M., Babb S.D., King B.A., Neff L.J. Current cigarette smoking among adults—United States, 2016. MMWR Morb. Mortal. Wkly. Rep. 2018;67:53–59. doi: 10.15585/mmwr.mm6702a1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of Bladder Cancer. Med Sci (Basel). 2020;8(1):15. Published 2020 Mar 13. doi:10.3390/medsci8010015
SEER . In: SEER Cancer Statistics Review 1975–2015. Noone A.M., Howlader N., Krapcho M., Miller D., Brest A., Yu M., Ruhl J., Tatalovich Z., Mariotto A., Lewis D.R., et al., editors. National Cancer Institute; Bethesda, MD, USA: 2018. [Google Scholar]
Xiong J, Yang L, Deng Y-Q, et al. The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study. Int J Cancer. 2022; 151(12): 2136-2143. doi:10.1002/ijc.34228
Nashaat Nabil Kamal; Asmaa Mohamed El Amin Mahmoud; Mona Abo Zeid Khalifa; Khaled Hussein Mohammed; Ebtesam Esmail Hassan. "Association between smoking and urinary bladder cancer (BC): case control study in Minia, Egypt". Minia Journal of Medical Research, 34, 1, 2023, 279-288. doi:
21608/mjmr.2023.181521.1246
Kwan ML, Haque R, Young-Wolff KC, et al. Smoking Behaviors and Prognosis in Patients With Non–MuscleInvasive Bladder Cancer in the Be-Well Study. JAMA Netw Open. 2022;5(11):e2244430. doi:10.1001/jamanetworkopen.2022.44430
Kispert, S., Marentette, J., & McHowat, J. (2019). Cigarette smoking promotes bladder cancer via increased platelet-activating factor. Physiological reports, 7(3), e13981. https://doi.org/10.14814/phy2.13981
Ho, Chung-Han & Tseng, Wen-Hsin & Huang, Steven & Liu, Chien-Liang & Wu, Yu-Cih & Chiu, Allen & Ong, Khaa. (2022). Association between Smoking and Overall and Specific Mortality in Patients with Bladder Cancer: A Population-based Study. Bladder Cancer. 8. 1-10. 10.3233/BLC-211583.
Agaku, I. T., B. A. King, and S. R. Dube. 2014. Current cigarette smoking among adults - United States, 20052012. MMWR Morb. Mortal. Wkly Rep. 63:29–34.
Bjurlin, M. A., M. R. Cohn, V. L. Freeman, L. M. Lombardo, S. D. Hurley, and C. M. Hollowell. 2012. Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases. J. Urol. 188:724– 728.
Silverman, D., S. L. M. Devesa, and N. Rothman. 2006. Bladder cancer. Pp. 1101–1127 in D. Schottenfeld and J.F. Jr. Fraumeni, eds. Cancer epidemiology and prevention. Oxford University Press, New York, NY.
Freedman, N. D., D. T. Silverman, A. R. Hollenbeck, A. Schatzkin, and C. C. Abnet. 2011. Association between smoking and risk of bladder cancer among men and women. JAMA 306:737–745
Bussolino, F., M. Arese, G. Montrucchio, L. Barra, L. Primo, R. Benelli, et al. 1995. Platelet activating factor produced in vitro by Kaposi’s sarcoma cells induces and sustains in vivo angiogenesis. J. Clin. Invest. 96:940– 952.
Imaizumi, T. 1991. Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking. Lipids 26:1269–1273.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
